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ABSTRACT We have cloned a full-length 1.6-kilobase cDNA
of a human mRNA coding for hypoxanthine phosphoribosyltrans-
ferase (HPRT; IMP:pyrophosphate phosphoribosyltransferase,
EC 2.4.2.8) into a simian virus 40-based expression vector and
have determined its full nucleotide sequence. The inferred amino
acid sequence agrees with a partial amino acid sequence deter-
mined for authentic human HPRT protein.. Transfection of HPRT-
deficient mouse IA9 cells with the purified plasmid leads to the
expression of human HPRT enzyme activity in cells stably trans-
fected and selected for enzyme activity in hypoxanthine/ami-
nopterin/thymidine medium.
Current methods of molecular biology, including the tech-
niques of recombinant-DNA construction and cloning, rapid
nucleotide sequence analysis, the design and construction of
transducing vectors, and techniques oftransfection ofeukaryot-
ic cells with foreign genes, have made it possible to clone and
characterize a large number of eukaryotic genes. One gene of
particular interest, not only for basic studies of eukaryotic gene
regulation but also for understanding of several important hu-
man genetic diseases, is the gene encoding the enzyme hypo-
xanthine phosphoribosyltransferase (HPRT) (1). This enzyme
catalyzes vital steps in the reutilization pathway for purine bio-
synthesis, and its deficiency leads to forms ofgouty arthritis and
to the devastating Lesch-Nyhan disease (2, 3). The HPRT locus
is known to be X linked in the human and other mammalian
genomes, and the availability of a cloned HPRT gene would
facilitate studies of the organization ofa particularly interesting
region of the human X chromosome and of the mechanisms of
inactivation of specific and well-mapped regions of the X chro-
mosome. Recently, we succeeded in isolating a human genomic
clone containing a portion ofthe HPRT gene together with some
intervening sequence (4). This fragment of the HPRT gene has
been used to isolate a full-length cDNA clone encoding the
human HPRTenzyme from a human cDNA library. Nucleotide
sequence analysis ofthe cloned cDNA segment established that
it encodes the entire HPRT protein.
METHODS
Isolation of the HPRT Gene Fragment. A genomic segment
of human DNA containing sequences from the extreme 5' end
of the HPRT gene together with a portion of an intervening
sequence has been isolated and cloned as plasmid p6B2aE2 (4)
by a combination of gene transfection into enzyme-deficient
mouse cells and localization ofhuman sequences by hybridiza-
tion with probes of middle repetitive human (Alu) sequence,
as described (4). A 15-kilobase (kb) EcoRI/BamilI fragment
derived from p6B2aE2 and free ofrepetitive human sequences
,has been subcloned into the BamHI and EcoRI-sites ofpBR322
and shown to hybridize to a discrete human cytoplasmic
poly(A)+RNA approximately 1.5 kb long, presumably. repre-
senting the mRNA for HPRT (4). DNA from this subcloned
plasmid, called pBR1.5, was prepared by detergent lysis (5) of
chloramphenicol-treated (6) transformed SF8 Escherichia coli
(7) followed. by cesium chloride/ethidium bromide ultracentri-
fugation (8). This DNA was cleaved with EcoRI/BamrHI and the
cloned insert was isolated by trough electroelution onto a di-
alysis membrane (9) after agarose.gel electrophoresis. It was
labeled by nick-translation (10) with [32P]dATP (3,000 Ci/
mmol; 1.Ci = 37 GBq; Amersham) in the presence of unlabeled
dCTP/dGTP/dTTP to a specific activity of approximately 2
X l08,cpm/,ug and was thereafter-used in hybridization studies
to screen a human cDNA.library.
Preparation and Screening ofa Human cDNA Library. The
preparation of the.complete.human cDNA library and the sub-
libraries containing different.size cDNA inserts is described in
detail elsewhere (11). Plasmid DNA representative of the com-
plete.and sublibraries. was transformed into actively growing
cultures of E. coli SF8 (OD6w = 0;6) by the method of Lerach
et at (12). Transformed colonies were selected by growth over-
night at 370C on Penassay base agar (Difco Laboratories) con-
taining ampicillin at 25-50 Ag/ml (Sigma) in 400-cm2 Petri
dishes (Nunc Bio-assay plates) at one dish per transformation.
Approximately 300,000 transformants per library were grown
and replica plated twice with velvet. E. coli SF8 containing the
cloned HPRT fragment (p6B2aE2) was plated as a positive con-
trol.
The colonies on the replica plates were transferred to What-
man 541 paper, amplified on chloramphenicol plates overnight
at 37QC by the method ofGergen et at (13), denatured and fixed
to the filters, and screened for HPRT cDNA sequences by hy-
bridization with the gel-purified insert from pBR1.5 containing
the HPRT fragment free ofrepeat sequences. The filter replicas
of the random colony arrays from each library were prehybri-
dized for 4 hr at 600C in 30% formamide/0.5 M NaCl/20 mM
Hepes, pH 7.4/0.1 mM EDTA/10 mM NaH2PO4/10 mM
Na4P207 containing denatured -and sonicated herring sperm
DNA at 500 ,g/ml (buffer A) and then hybridized to the 32p-
labeled nick-translated pBR1.5 insert fragment. overnight at
600C in buffer A/10% dextran sulfate. The filter sheets were
Abbreviations: HPRT, hypoxanthine- phosphoribosyltransferase; kb,
kilobase(s); HAT, hypoxanthine/aminopterin/thymidine; bp, base
pair(s).
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then washed twice with 0.30 M NaCl/0.030 M Na citrate, pH
7.4, and then with 60 mM NaCl/6mM Na citrate, pH 7.4, once
at 60'C and twice at room temperature. Filters were dried and
autoradiographed on flashed Kodak XAR-5 film with an inten-
sifying screen at -700C.
Areas showing a putative positive signal on duplicate filters
were identified, scraped with a toothpick onto 1 ml of Penassay
broth, plated at various concentrations from the broth, and
grown overnight. Single colonies were transferred with a tooth-
pick, into arrays, grown overnight, and rescreened on Whatman
541 paper as described above.
DNA "minipreps" (14) were prepared from apparently pos-
itive colonies derived from the one original positive area from
the transformation with sublibrary 4 (11), which contains inserts
of 1.5-2.0 kb of DNA. The cDNA inserts were screened with
32P-labeled nick-translated purified insert DNA from pBRI.5
by blotting agarose gels containing whole DNA or BamHI di-
gests onto nitrocellulose according to Southern (15), treatment
with HCl (16), and hybridization as described above for the
cDNA library, with the addition of 5-fold concentrated Den-
hardt's additives (17) to the prehybridization and hybridization
buffers.
All manipulations involving recombinant DNA were carried
out in accordance with National Institutes of Health and insti-
tutional guidelines and requirements.
Transfection, of Enzyme-Deficient Cells. The isolated full-
length cDNA plasmid was introduced into enzyme-deficient
mouse LA9 cells grown in Dulbecco's modified Eagle's medium/
10% calf serum by calcium phosphate-mediated transfection as
described (4, 18), and the resulting HPRT-positive cells were
selected by growth in hypoxanthine/aminopterin/thymidine
(HAT) selective medium (19). Colonies were picked through
cloning cylinders and grown in the selective medium.
Gel Assay for HPRT Enzyme Activity. After isoelectric fo-
cusing in polyacrylamide gels, cytoplasmic extracts of trans-





\E > . -
.. _ ,,,
FIG. 2. Transfection of mouse LA9 cells with the HPRT clone
p4aA8 (Left) and a control clone, p4aB8. (Right). Approximately 106
HPRT-deficient LA9 cells per plate were transfected with 1 jg of plas-
mid together with 20 ,ug of LA9 carrier DNA, grown in HAT medium
after transfection, and stained with Giemsa,
fected and control, cells were assayed for HPRT activity by the
method of Johnson et aL (20).
Cloning of p4aA8 cDNA Fragments into M13. Plasmid
p4aA8 was treated with BamHI and electrophoresed on a prep-
arative 1% agarose gel in Tris acetate buffer (21). Subclones in
M13 mp8 were generated by the method of P. Deininger (per-
sonal communication). Briefly, the 1.6-kb BamHI fragment
from p4aA8 was electroeluted (9), ligated into-a multimer, and
sonicated to give random shear fragments of200-800 base pairs
(bp), which were ligated into the Sma I-cut phosphatase-treated
M13 mp8 vector. The ligation mixture was used to transfect E.
coli JM 101 (22).
DNA Sequence Analyses. Single-stranded template was pre-
pared from white M13 plaques and used for sequence deter-
mination by the dideoxy chain-termination methods of Messing
et al. (22) and Sanger et al. (23) using an M13 pentadecamer
primer (New England BioLabs).
HPBRT Amino Acid Sequence Determination. Authentic hu-
man HPRT enzyme was purified as described by Johnson et al.
(24) and tryptic peptides were prepared and purified by HPLC
(25). The amino acid sequences of several of the peptides were
determined by microanalysis using a modified spinning cup
method (26-28).
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FIG. 1. Structure of the HPRT cDNA plasmid (p4aA8). Purified
plasmid DNA was digested to completion with BamHI, electropho-
resed on a 1% agarose gel, stained, and photographed, and the DNA
was blotted onto nitrocellulose paper. The paper was hybridized to the
32P-labeled insert from pBR1.5 in 10% formamide/0.5 M NaCl/0.1
mM EDTA/50 mM Hepes, pH 7.4, at 60°C, washed, and exposed to x-
ray film. (Left) X-ray film of the hybridized blot. (Right) Photograph
of the ethidium bromide-stained gel. Lanes: 1, p4aB8 (a randomly
picked control plasmid); 2, p4aA8 (the HPRT cDNA plasmid); 3,
HindIII-digested bacteriophage markers (from top to bottom): 23.6,
9.6, 6.6, 4.3, 2.3, 2.0, and 0.55 kb (29). Arrow, the heavily hybridizing




FIG. 3. Gel assay for HPRT activity of transfected mouse LA9
cells. Polyacrylamide isoelectric focusing gels loaded with cell lysates
from different cell types were assayed for enzyme activity, and results
were detected by autoradiography. OH- and H+, alkaline and acid ends
of the gel; M and H, major mouse and human HPRT activities. (Both
human and mouse HPRT also display a minor band of activity at a
lower pI.) Lanes: 1, 3T6 mouse cells; 2, a line of cells derived from LA9
cells transfected toHAT resistance with p4aA8 and makingHPRT that
has human isoelectric focusing properties; 3, as in lane 2 but a sepa-
rately derived cell line; 4, HeLa (human) cells; 5, 3T6 mouse cells; 6,
LA9 HPRT- cells, the parent of the cell lines in lanes 2 and 3.
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RESULTS isolated previously (4), thought to contain a portion ofthe HPRT
Approximately 300,000 colonies of the cDNA library were coding sequence and some HPRT intervening sequence. One
transferred from nutrient-containing plates to filters and hy- reproducibly hybridizing colony was found on duplicate filters,bridized with the nick-translated insert from plasmid pBR1.5, and it was picked, colony purified, and grown to prepare large
GGGGGGGGGGGGGGTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCACCGGCTTCCT
10 20 30 40 50 60
met ala thr arg ser pro glyCCTCCTGAGCAGTCAGCCCGCGCGtCCGGCCGGCTCCGTTATGGCGACCCGCAGCCCTGGC70 80 90 100 110 120
val val Hie ser asp asp glu pro gly tyr asp leu asp leu phe cys ile pro asn hisGTCGTGATTAGTGATGATGAACCAGGTTATGACCTTGATTTATTTTGCATACCTAATCAT
130 140 150 160 170 180
tyr ala glu asp leu glu arg (val phe ile pro his gly leu ile) met (asp arg thr gluTATGCTGAGGATTTGGAAAGGGTGTTTATTCCTCATG GACTAATTATG'GACAGGACT GAA
190 200 210 220 230 240
arg leu ala arg asp val met) lys glu met gly gly his his lie val ala leu cys val
CG'TCTTGCTCGAGATGTGATGAAGGAGATGGGAGGCCATCACATT GTAGCCCTCTGTGTG
250 260 270 280 290 300
leu lys gly gly tyr lys phe phe ala asp leu leu asp tyr ile lys ala leu asn arg
CTCAAGGGGGGCTATAAATTCTTTGCTGACCTGCTGGATTACATCAAAGCACTGAATAGA
310 320 330 340 350 360
asn ser asp arg ser ile pro met thr val asp phe ile arg leu lys (ser tyr cys asn
AATAGTGATAGATCCATTCCTATGACTGTAGATTTTATCAGACTGAAGAGCTATTGTAAT370 380 390 400 410 420
asp gin ser thr gly asp ile lys) val ile gly gly asp asp leu ser thr leu thr gly
GACCAGTCAACAGGGGACATAAAAGTAATTGGTGGAGATGATCTCTCAACTTTAACTGGA
430 440 450 460 470 480
lys (asn val leu ile val glu asp ile ile asp thr gly lys) thr met gln thr leu leu
AAGAATGTCTTGATTGTGGAAGATATAATTGACACTGGCAAAACAATGCAGACTTTGCTT
490 500 510 520 530 540
ser leu val arg gin tyr asn pro lys met val lys val ala ser leu leu val lys arg
TCCTTGGTCAGGCAGTATAATCCAAAGATGGTCAAGGTCGCAAGCTTGCTGGTGAAAAGG
550 560 570 580 590 600
thr pro arg ser val gly tyr lys pro asp phe val gly phe glu lie pro asp lys phe
ACCCCACGAAGTGTTGGGATATAAGCCAGACT'TTGTTGGATTTGAAATTCCAGACAAGTTT
610 620 630 640 650 660
val val gly tyr ala leu asp tyr asn glu tyr phe arg (asp leu asn his val cys val
GTTGTAGGATATGCCCTTGACTATAATGAATACTTCAGGGATTTGAATCATGTTTGTGTC
670 680 690 700 710 720
ile ser glu thr gly lys ala lys) tvr lys ala ***
ATTAGTGAAACTGGAAAAGCAAAATACAAAGCCTAAGATGAGAGTTCAAGTTGAGTTTGG
730 740 750 760 770 780
AAACATCTGGAGTCCTATTGACATCGCCAGTAAAATTATCAATGTTCTAGTTCTGTGGCC
790 800 810 820 830 840
850 860 870 880 890
GAAATGTCAGTTGCTGCATTCCTAAACTGTTTATTTGCACTATGAGCCTATAGACTATCA
910 920 930 940 950 960
GTTCCCTTTGGGCGGATTGTTGTTTAACTTGTAAATGAAAAAATTCTCTTAAACCACAGC
970 980 990 1000 1010 1020
ACTATTGAGTGAAACATTGAACTCATATCTGTAAGAAATAAAGAGAAGATATATTAGTTT
1030 1040 1050 1060 1070 1080
TTTAATTGGTATTTTAATTTTTATATATGCAGGAAAGAATAGAAGTGATTGAATATTGTT
1090 1100 1110 1120 1130 1140
AATTATACCACCGTGTGTTAGAAAAGTAAGAAGCAGTCAATTTTCACATCAAAGACAGCA
1150 1160 1170 1180 1190 1200
1210 1220 1230 1240 1250 1260
ATTTTCCAACTTGTTCAAATTATTACCAGTGAATCTTTGTCAGCAGTTCCCTTTTAAATG
1270 1280 1290 1300 1310 1320
CAAATCAATAAATTCCCAAAAATTTAAAAAAAAAAA
1330 1340 1350
FIG. 4. Nucleotide sequence of human HPRT cDNA and inferred amino acid sequence. ThecDNA sequence was determined by dideoxy sequence
analysis of M13 mp8 recombinant clones. Fifty-three independent cloned fragments having a random distribution within the cDNA were analyzed
and their sequences were assembled according to their overlapping regions. All of the DNA sequence was confirmed on independent clones and,
for about 85% of the cDNA fragment, both strands of the sequence were analyzed. Verified amino acid sequences of isolated peptides from purified
human HPRT are shown in parentheses. We have assumed that translation begins at the first available AUG codon (at base 86) and terminates
at the first chain-termination codon in the single open reading frame (i.e., at the UAA codon marked by asterisks at base 740). A potential poly-
adenylylation site, A-A-T-A-A-A, occurs at base
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amounts of plasmid DNA. Digestion of this purified plasmid
(p4aA8) DNA with BamHI yielded an insert of approximately
1.6 kb (Fig. 1). The cloning vector has two BamHI sites that
flank the cloned cDNA segment. If the cloned cDNA segment
does not contain a BamHI restriction site, digestion with
BamHI will excise the complete cDNA sequence flanked at the
5' end by about 100 bp derived from simian virus 40 DNA and
the G-C joint and at the 3' end by 100-200 bp containing the
APT joint and simian virus 40 DNA.
Transfection of mouse HPRT-deficient LA9 cells with the
HPRT cDNA'p4aA8 resulted in the appearance of HAT-resis-
tant colonies at a frequency of approximately 1 per 103 cells
when 1 tig of plasmid and LA9 carrier DNA was used (Fig. 2).
Transfection of these cells with a control plasmid picked at ran-
dom from the library (p4aB8) failed to produce any HAT-resis-
tant colonies. Lysates from two HAT-resistant colonies were
tested for HPRT activity byan isoelectric focusing gel assay (Fig.
3). Both colonies contained enzyme activities that cofocused
with the major band ofauthentic human HeLa marker enzyme,
as opposed to the major and minor bands of enzyme activity
derived from mouse 3T6 cells.
Fragments ofthe isolated 1.6-kb insert were cloned into M13
mp8 and their sequences were determined. The nucleotide se-
quence of the insert spanning the G-C to the APT tailing regions
is presented in Fig. 4 together with the inferred amino -acid
sequence ofthe encoded polypeptide and the tryptic and cyano-
gen bromide peptides whose sequences were determined in-
dependently. In the five peptides (a total of 56 amino acids),
there are no disagreements between the amino acid sequences
and the nucleotide sequences determined.
DISCUSSION
Three important prerequisites were satisfied for the successful
cloning of full-length human HPRT cDNA. First, a probe con-
taining HPRT coding sequence was isolated by a combination
of transfection of human DNA into enzyme-deficient mouse
cells and identification of the human sequences in such trans-
fected cells by their hybridization to human repetitive (Alu)
sequences or to total human DNA. Second, a cDNA library,
preferably one likely to contain a full-length cDNA segment was
prepared by using the procedure outlined previously (30),
which has been further developed to allow expression of full-
length cDNA sequences in mammalian cells (11). The simian
virus 40-pBR322-based cloning vector contains a simian virus
40 early region promoter and intron 5' to the cDNA segment
and a polyadenylation signal 3' to the cDNA segment. These
permit the expression of inserted cDNA sequences. In this in-
stance, they permitted a direct test of the function of putative
HPRT cDNA sequences in transfection assays and enabled us
to identify and confirm full-length HPRT sequences. Third, it
happened that pBRL.5 hybridizes to the 5' end of the cDNA
clone (this was shown by hybridization to M13 subclones) and
hence its use as a hybridization probe selectively detected full-
length or nearly full-length cDNA clones. This correlates with
the observation that mouse sequences exist in this subcloned
plasmid and at one end ofthe original genomic clone (p6B2aE2)
and, hence, implies that the site of 5' linkage of the exogenous
human HPRT gene to mouse sequences is cloned in these plas-
mids.
When individual size classes of the cDNA library were hy-
bridized with a fragment between positions 142 and 1,221 in
the nearly full-length HPRT cDNA (Fig. 4), additional positive
clones were found in the various sublibraries. The frequency
of HPRT-positive clones in the library was about 2 X 10-5 or
equivalent to approximately 2-5 copies of HPRT mRNA per
cell. We estimate the frequency offull-length cDNA clones rel-
ative to the total number of positive clones in the complete li-
brary to be about 5%.
The sequence-of the cDNA insert between the G.C and APT
linkers has been fully determined. The cDNA sequence is just
under 1,350 nucleotides long, in good agreement with the size
(approximately 1,600 bp) predicted from the RNA blots hy-
bridized to pBRL.5 (4). It is not known whether some 5' se-
quences are missing in the cDNA clone, but the 85-bp 5'-non-
translated region is in the usual size range for eukaryotic mRNA
leader sequences. The coding sequence occupies 654 bp,
slightly less than half of the full length of the cDNA, leaving a
3'-noncoding tail of approximately 600 nucleotides. The orga-
nization is typical of eukaryotic mRNA sequences; in which the
major noncoding region is usually 3' to the coding sequences
(31).
The single open frame encodes a polypeptide 218 amino acids
long, indicating a molecular weight of approximately 24,600.
Post-translational removal of the NH2-terminal methionine
would result in a protein 217 amino acids long, with a molecular
weight of 24,450. The purified human HPRT enzyme has been
estimated to have a molecularweight of24,000-26,000 (32, 33).
In addition, the partial amino acid composition of the purified
enzyme is in complete agreement with our inferred amino acid
composition. Most impressively, the inferred amino acid se-
quence is in complete agreement with the full amino acid se-
quence of the human erythrocyte HPRT enzyme recently de-
termined by Wilson et aL (34). This sequence indicates that the
NH2-terminal methionine is indeed cleaved in the fully pro-
cessed mature enzyme.
The protein has no obvious large hydrophobic or hydrophilic
domains but instead has small alternating regions of hydropho-
bic and hydrophilic regions, suggesting a compact and globular
structure. We predict that human HPRT is not a membrane
constituent.
Caskey and co-workers (35, 36) have used a different ap-
proach in their isolation of a cDNA clone of the mouse HPRT
gene, taking advantage of cells overproducing HPRT (35, 36).
They have determined the sequence of mouse HPRT cDNA,
and comparison of the inferred mouse and human amino acid
sequences shows only eight differences, and the lengths of the
polypeptides are identical.
We expect that this cDNA clone will be useful for studying
the organization of normal and mutant human HPRT genes, for
examining the mechanisms of X-chromosome inactivation, for
studying the fate and expression ofHPRT cDNA in transfected
HPRT-deficient mouse and human cells, and for examining the
distribution and expression of HPRT sequences in mice after
introduction of the gene into the male pronucleus of fertilized
mouse eggs.
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